OakChart

TOMI Environmental Solutions Inc

TOMZIndustrials·Pollution & Treatment Controls·USA·Nano·NASD·Nov 11 • 3:59 PM ET

2.52-0.11 (-4.18%)
2026-11-12 03:34 CET
Market cap
20.52 USD m
Revenue, TTM
6.93 USD m
Net income, TTM
-3.45 USD m
Free cash flow, TTM
-2.04 USD m
EPS diluted, TTM
-0.61
P/E
-
Compare

Price

TOMZ against its 20, 50 and 200-day averages
2050200earnings
1.502.002.503.001.1M2.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TOMZclose 2.5220-day 1.8550-day 1.66200-day 1.972.5252w high52w low

22.3% under the 52-week high of 3.24 on 4 Jun 2026. 52-week low 1.21 on 30 Sep 2026. Last 15 sessions, 115.5% high to low

Volume 0.27× normal · the line is the 50-bar volume average

Profile

TOMZ
52-week range, 65% of the way up
1.213.24

TOMI Environmental Solutions, Inc. provides disinfection and decontamination essentials under the brand name SteraMist. It operates through the following divisions: Hospital-HealthCare, Life Sciences, Commercial, and Food Safety. The company was founded by Halden S. Shane on September 18, 1979 and is headquartered in Frederick, MD.

Employees20
IPOJun 20, 2008
Beta1.93
ATR, 14d0.27
Rel volume0.27
Short float0.29%
Insider own36.10%
Inst own4.32%

Snapshot

6 groups

Valuation

Index-
Market Cap20.51M
Enterprise Value23.58M
Income-3.45M
Sales6.93M
Book/sh0.53
Cash/sh0.04
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees20
IPOJun 20, 2008

Ratios

P/E-
Forward P/E21.00
PEG-
P/S2.96
P/B4.79
P/C64.11
P/FCF-
EV/EBITDA-
EV/Sales3.40
Quick Ratio0.67
Current Ratio1.49
Debt/Eq2.37
LT Debt/Eq2.27
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.61
EPS next Y0.12
EPS next Q0.09
EPS this Y87.72%
EPS next Y271.43%
EPS next 5Y-
EPS past 3/5Y-8.56% -
Sales past 3/5Y-12.24% -25.78%
EPS Y/Y TTM13.68%
Sales Y/Y TTM11.42%
EPS Q/Q18.47%
Sales Q/Q117.91%
EarningsNov 12 AMC
EPS/Sales Surpr.- 0.00%

Ownership

Insider Own36.10%
Insider Trans0.00%
Inst Own4.32%
Inst Trans2.59%
ROA-40.92%
ROE-168.84%
ROIC-73.84%
Gross Margin49.48%
Oper. Margin-40.95%
Profit Margin-49.77%
SMA2036.40%
SMA5052.17%
SMA20028.09%
Trades-

Technical

Shs Outstand8.14M
Shs Float5.20M
Short Float0.29%
Short Ratio0.21
Short Interest0.01M
52W High3.24 -22.29%
52W Low1.21 108.26%
Volatility16.79% 15.89%
ATR (14)0.27
RSI (14)74.10
Beta1.93
Rel Volume0.27
Avg Volume69.48K
Volume19,019

Performance

Perf Week13.00%
Perf Month52.73%
Perf Quarter34.76%
Perf Half Y4.22%
Perf YTD7.69%
Perf Year-5.07%
Perf 3Y-9.20%
Perf 5Y-33.33%
Perf 10Y-69.12%
Recom1.00
Target Price7.00
Prev Close2.63
Price2.52
Change %-4.18%

Peers

Mkt cap
TickerCompanyMkt cap
LIQTLiqTech International Inc10.25M
CLIRClearSign Technologies Corp16.20M
BCHTBirchtech Corp28.94M
ARQArq Inc137.87M
APTAlpha Pro Tech Ltd63.89M
NEPHNephros Inc33.37M
STESteris Plc24.89B
CLHClean Harbors Inc15.29B
ECLEcolab Inc86.34B
LAKELakeland Industries Inc93.50M

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200
  • TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12 (GlobeNewswire)
  • TOMI Environmental Solutions, Inc. Announces Recurring Consumable Agreement with Global Eye Health Company (GlobeNewswire)
  • TOMI's Breakeven Bet Meets A $12 Million Target That Demands A Second-Half Surge (Earnings Whispers) +11.92%
  • TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2026 Financial Results on November 6, 2026 (GlobeNewswire)
  • TOMI Environmental Solutions Secures Three-Phase SteraMist iHP Order from Mexican Pharmaceutical Manufacturer Zeyco (GlobeNewswire)
  • TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls (GlobeNewswire)
  • TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year (GlobeNewswire)
  • TOMI Environmental Solutions Confirms Readiness to Support Biosecurity Preparedness and Front-Line Response Worldwide (GlobeNewswire)
  • TOMI Environmental Solutions Expands SteraMist iHP into India's Pharmaceutical Market Through Partner STS Technocrat (India) Pvt. Ltd. (GlobeNewswire) +7.09%
  • Project MEND Uses SteraMist to Safely Disinfect Medical Equipment for Reuse (GlobeNewswire) -8.63%
  • TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy (GlobeNewswire)
  • TOMI Environmental Solutions Announces Mutual Termination of Merger Agreement with Carbonium Core (GlobeNewswire)
  • TOMI Environmental Solutions Reports Accelerating Growth in SteraMist Service Revenue (GlobeNewswire) -7.59%
  • TOMI's SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-060.0000.000-0.4803.013.011
2026Q22026-08-14-0.050-0.110-0.4802.251.841
2026Q12026-05-08-0.120-0.120-0.1191.651.691
2025Q42026-03-31-0.300-0.060-0.2691.022.311
2025Q32025-11-14-0.060-0.030-0.0672.012.741
2025Q22025-08-14-0.180-0.090-0.1851.031.801
2025Q12025-05-08-0.030-0.150-0.0381.581.541
2024Q42025-04-14-0.1500.030-0.4881.303.401
2024Q32024-10-300.0000.0000.0092.543.871
2024Q22024-08-010.000-0.1200.0043.012.831
2024Q12024-05-15-0.210-0.060-0.1971.112.601
2023Q42024-04-01-0.180-0.030-0.1851.532.861
2023Q32023-11-14-0.150-0.060-0.1361.472.851
2023Q22023-08-140.0000.030-0.0132.774.001
2023Q12023-05-15-0.180-0.060-0.1801.582.901
2022Q42023-03-16-0.1200.000-0.1072.812.971

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-0.750-0.540-0.7597.758.50
2022FY-0.450-0.330-0.4388.348.50
2023FY-0.510-0.360-0.5157.358.69
2024FY-0.300-0.150-0.6727.9710.10
2025FY-0.570-0.360-0.6605.646.93
2026FY--0.070--11.94
2027FY-0.120--18.17
2028FY-0.270--23.09
2029FY-0.420--27.88
2030FY-0.560--32.44

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-061005.025.025.02
2026Q4S2026-10-311005.025.025.02
2026Q4S2026-08-171105.025.025.02
2026Q4S2026-08-141002.592.592.59
2026Q4S2026-05-111002.592.592.59
2026Q4S2026-04-131002.592.592.59
2026Q4E2026-11-061000.090.090.09
2026Q4E2026-10-311000.090.090.09
2026Q4E2026-08-171100.090.090.09
2026Q4E2026-08-14110-0.08-0.08-0.08
2026Q4E2026-07-29110-0.08-0.08-0.08
2026Q4E2026-05-11100-0.09-0.09-0.09
2026Q4E2026-04-13100-0.09-0.09-0.09
2026Q3S2026-10-311003.013.013.01

Estimate history

EPS, annual-0.72-0.627-0.4420.702-0.759-0.438-0.515-0.672-0.56-0.6065
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0040.009-0.488-0.038-0.185-0.067-0.269-0.119-0.151
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual4.9945.5856.34725.0287.7548.3387.3557.7395.6366.93
Period201720182019202020212022202320242025TTM
Sales, quarterly3.0132.5421.0691.5771.0312.0121.0171.6542.247
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual5.0855.1795.1965.5876.566.5886.6416.6726.7592.714
Period201720182019202020212022202320242025MRQ
Shares, quarterly6.6726.6726.6726.6726.6726.6926.7596.8992.714
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue6.935.647.747.358.347.7525.036.355.58
Cost of Goods Sold Incl. D&A3.502.834.483.433.613.4610.703.153.10
Gross Profit3.432.813.263.924.734.2914.323.202.48
Selling, General and Administrative Excl. Other6.276.667.377.277.619.229.815.285.55
Research and Development0.260.290.290.490.350.570.460.340.92
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.84-3.85-4.10-3.35-2.88-4.924.51-2.08-3.07
Interest Expense0.610.520.390.070.000.000.040.220.26
Unusual Expense0.00-0.530.000.000.00-0.410.000.00-0.09
Net Income Before Taxes-3.45-3.75-4.48-3.40-2.88-4.514.47-2.30-3.23
Income Taxes0.000.000.000.000.00-0.070.080.000.00
Consolidated Net Income-3.45-3.75-4.48-3.40-2.88-4.444.39-2.30-3.23
Net Income From Continuing Operations-3.45-3.75-4.48-3.40-2.88-4.444.39-2.30-3.23
Net Income-3.45-3.75-4.48-3.40-2.88-4.444.39-2.30-3.23
EPS (Recurring)-1.36-0.62-0.67-0.51-0.44-0.810.70-0.44-0.64
EPS (Basic, Before Extraordinaries)-0.61-0.56-0.67-0.51-0.44-0.760.80-0.44-0.63
EPS (Diluted)-0.61-0.56-0.67-0.51-0.44-0.760.70-0.44-0.63
EBITDA-2.52-3.57-3.79-2.97-2.53-4.435.43-1.18-2.44
Non-Operating Income (Expense)0.000.090.020.010.000.000.000.000.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.000.140.160.650.022.290.110.08
Price To Earnings Ratio------20.49--
Price To Sales Ratio0.902.782.712.721.163.733.432.222.54
Gross Margin49.4849.7842.1353.3456.7455.3657.2350.3844.46
Operating Margin-40.95-68.39-53.04-45.54-34.56-63.5118.02-32.82-54.98
Net Margin-49.77-66.52-57.85-46.27-34.54-57.2117.55-36.20-57.85
Shares Outstanding2.716.766.676.646.596.565.595.205.18
Market Capitalization20.5220.5221.0220.029.7232.4776.6014.0714.29

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue2.251.651.022.011.031.581.072.54
Cost of Goods Sold Incl. D&A0.910.880.870.850.420.691.671.05
Gross Profit1.340.780.151.160.610.88-0.601.49
Selling, General and Administrative Excl. Other1.581.411.801.481.741.642.551.34
Research and Development0.040.060.150.010.080.040.100.06
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.24-0.63-1.65-0.32-1.13-0.75-3.150.15
Interest Expense0.140.180.160.130.110.120.110.09
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-0.38-0.81-1.81-0.45-1.24-0.26-3.260.06
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-0.38-0.81-1.81-0.45-1.24-0.26-3.260.06
Net Income From Continuing Operations-0.38-0.81-1.81-0.45-1.24-0.26-3.260.06
Net Income-0.38-0.81-1.81-0.45-1.24-0.26-3.260.06
EPS (Recurring)-0.15-0.12-0.27-0.07-0.19-0.04-0.490.01
EPS (Basic, Before Extraordinaries)-0.15-0.12-0.27-0.07-0.19-0.04-0.490.01
EPS (Diluted)-0.15-0.12-0.27-0.07-0.19-0.04-0.490.01
EBITDA-0.15-0.53-1.58-0.25-1.06-0.68-3.070.22
Non-Operating Income (Expense)0.003E-050.000.000.000.620.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.040.150.000.00-0.000.00
Price To Sales Ratio0.901.982.793.563.432.002.721.94
Gross Margin59.4347.0914.8857.8358.9556.02-56.2558.66
Operating Margin-10.87-37.86-161.87-15.98-109.85-47.86-294.565.86
Net Margin-17.01-49.00-177.59-22.39-120.02-16.21-304.532.32
Shares Outstanding2.716.906.766.696.676.676.676.67
Market Capitalization20.5211.4515.8220.2821.3216.4121.0215.86

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments0.090.662.343.875.325.200.902.004.55
Short Term Receivables0.691.882.592.942.203.921.492.151.84
Inventories3.093.614.664.945.034.172.322.793.52
Other Current Assets0.320.330.370.390.340.420.330.300.27
Total Current Assets4.196.499.9612.1312.8913.715.047.2410.18
Net Property, Plant & Equipment0.941.271.521.862.071.932.041.590.71
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable-0.000.21------
Intangible Assets1.351.251.121.030.970.781.031.241.55
Deferred Tax Assets0.10-------0.00
Other Assets0.560.680.550.480.340.360.110.010.00
Total Assets7.139.6913.3615.5016.2716.778.2310.0812.44
Short Term Debt Incl. Current Port. of LT Debt0.400.130.120.100.090.085.070.000.00
Accounts Payable1.481.921.271.761.051.500.711.130.75
Income Tax Payable----0.000.090.02--
Other Current Liabilities1.280.670.681.430.670.530.490.570.35
Total Current Liabilities3.162.722.063.291.822.206.301.701.10
Long Term Debt3.282.872.940.760.861.361.034.985.94
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.10-------0.00
Other Liabilities0.000.000.000.000.000.000.000.400.00
Total Liabilities6.545.595.004.052.683.577.347.087.05
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.010.010.01
Common Equity0.594.108.3611.4513.5913.200.882.995.39
Total Shareholders Equity0.594.108.3611.4513.6013.200.893.005.39
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity0.594.108.3611.4513.6013.200.893.005.39
Total Liabilities & Stockholders Equity7.139.6913.3615.5016.2716.778.2310.0812.44
Book Value Per Share0.090.611.261.742.072.360.170.581.06
Tangible Book Value Per Share-0.110.431.091.581.922.22-0.030.340.76
Full-Time Employees202026302429211918
Price to Book Ratio4.795.132.110.822.395.8015.904.781.95
Return on Assets-44.56-38.84-23.58-18.13-26.8535.14-25.10-28.69-33.48
Return on Equity-159.96-71.87-34.36-23.00-33.1062.32-118.30-77.01-53.35
Return on Invested Capital-96.84-64.20-30.11-23.59-30.6830.15-119.43-40.49-32.10
Quick Ratio0.351.062.582.194.334.330.432.626.04
Current Ratio1.322.394.843.697.106.220.804.269.23

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3.45-3.75-4.48-3.40-2.88-4.444.39-2.30-3.23
Depreciation0.390.430.450.520.340.490.920.900.63
Other Funds (Non Cash)0.670.662.530.140.961.123.36-0.01-0.09
Funds from Operations-2.38-2.66-1.49-2.74-1.58-2.828.67-1.41-2.68
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.351.470.05-0.860.35-1.00-4.090.590.91
Cash from Operating Activities-2.03-1.20-1.44-3.60-1.23-3.824.58-0.81-1.77
Capital Expenditures-0.09-0.14-0.26-0.22-0.24-0.64-0.40-0.29-0.63
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.09-0.14-0.26-0.22-0.24-0.64-0.40-0.29-0.63
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.920.000.030.000.034.580.210.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.920.000.030.000.034.580.210.000.00
Proceedsfrom Stock Options1.920.000.000.000.004.580.000.000.00
Issuance or Reduction of Debt, Net-0.050.760.002.290.000.00-0.090.00-0.15
Change in Long Term Debt0.100.540.002.290.000.00-0.090.00-0.15
Issuance of Long Term Debt0.100.540.002.290.000.000.410.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-0.500.00-0.15
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities1.870.760.032.290.034.580.120.00-0.15
Net Change in Cash-0.25-0.58-1.67-1.53-1.450.124.30-1.11-2.55
Free Cash Flow-2.04-1.20-1.55-3.70-1.44-4.344.29-0.96-2.40
Price to Free Cash Flow------19.99--
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments0.320.280.090.490.570.67
Short Term Receivables1.890.760.690.621.052.39
Inventories3.043.163.093.593.523.44
Other Current Assets0.280.390.320.330.250.28
Total Current Assets5.534.594.195.035.406.78
Net Property, Plant & Equipment0.790.870.941.021.111.20
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.351.341.351.361.301.24
Deferred Tax Assets--0.10---
Other Assets0.710.660.560.630.660.74
Total Assets8.387.467.138.058.489.96
Short Term Debt Incl. Current Port. of LT Debt0.150.260.400.140.140.13
Accounts Payable1.602.101.481.261.001.77
Other Current Liabilities1.961.841.281.141.461.11
Total Current Liabilities3.714.203.162.542.593.01
Long Term Debt3.243.263.283.303.233.10
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--0.10---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities6.957.466.545.845.826.11
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1.43-0.000.592.212.663.84
Total Shareholders Equity1.430.000.592.212.663.84
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1.430.000.592.212.663.84
Total Liabilities & Stockholders Equity8.387.467.138.058.489.96
Book Value Per Share0.53-1E-050.090.330.400.58
Tangible Book Value Per Share0.03-0.19-0.110.130.200.39
Full-Time Employees--20---
Price to Book Ratio4.79-165,930.0026.919.198.034.27
Return on Assets-40.92-49.42-44.56-50.71-44.48-31.23
Return on Equity-168.84-223.94-159.96-108.76-94.24-62.68
Return on Invested Capital-8.19-24.84-46.64-8.18-21.04-3.68
Quick Ratio0.670.340.350.570.721.11
Current Ratio1.491.091.321.982.082.25

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-0.38-0.81-1.81-0.45-1.24-0.26
Depreciation0.090.090.100.110.110.11
Other Funds (Non Cash)-0.060.190.65-0.100.030.08
Funds from Operations-0.36-0.53-1.05-0.45-1.10-0.07
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.240.830.430.330.91-0.21
Cash from Operating Activities-1.590.30-0.62-0.11-0.19-0.28
Capital Expenditures-0.01-0.01-0.00-0.07-0.070.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.01-0.01-0.00-0.07-0.070.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock1.830.090.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1.830.090.000.000.000.00
Proceedsfrom Stock Options1.830.090.000.000.000.00
Issuance or Reduction of Debt, Net-0.370.000.220.100.150.28
Change in Long Term Debt0.000.000.000.100.150.28
Issuance of Long Term Debt0.000.000.000.100.150.28
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.19-0.190.000.000.000.00
Other Financing Activities Uses0.19-0.190.000.000.000.00
Cash from Financing Activities1.65-0.100.220.100.150.28
Net Change in Cash0.040.19-0.40-0.08-0.100.01
Free Cash Flow-1.590.29-0.62-0.11-0.19-0.28

Revenue breakdown

United States2024: 7.74M 2025: 5.64M
Total Industrial Organic Chemicals revenue2024: 7.74M 2025: 5.64M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.29%0.0M5.2M67.08K
2026-10-150.31%0.0M5.2M71.07K
2026-09-300.46%0.0M5.2M71.22K
2026-09-150.56%0.0M5.2M40.04K
2026-08-310.60%0.0M5.2M57.62K
2026-08-140.80%0.0M5.2M73.38K
2026-07-310.31%0.0M5.1M93.13K
2026-07-150.12%0.0M5.1M226.27K
2026-06-300.46%0.0M4.8M220.47K
2026-06-150.87%0.0M4.8M205.38K
2026-05-291.71%0.1M4.4M191.65K
2026-05-154.16%0.2M4.4M268.55K
2026-04-304.80%0.2M3.9M247.09K
2026-04-150.56%0.0M3.9M108.49K
2026-03-310.92%0.0M3.9M108.97K
2026-03-131.02%0.0M3.8M106.29K
2026-02-272.52%0.1M3.8M102.44K
2026-02-130.11%0.0M3.8M6.46K
2026-01-300.20%0.0M3.8M6.63K
2026-01-150.11%0.0M3.8M8.14K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-168-KCurrent report2026-10-11SEC
2026-09-218-KCurrent report2026-09-15SEC
2026-09-028-KCurrent report2026-09-01SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-208-KCurrent report2026-07-20SEC
2026-07-168-KCurrent report2026-07-16SEC
2026-06-298-KCurrent report2026-06-28SEC
2026-06-108-KCurrent report2026-06-04SEC
2026-06-05DEF 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-06-05SEC
2026-05-223Initial statement of beneficial ownership of securities2026-05-16SEC
2026-05-208-KCurrent report2026-05-19SEC
2026-05-19PRE 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-05-18SEC
2026-05-198-KCurrent report2026-05-16SEC
2026-05-088-KCurrent report2026-05-08SEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-22SEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-22SEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-22SEC
2026-04-158-KCurrent report2026-04-14SEC
2026-04-088-KCurrent report2026-04-08SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-318-KCurrent report2026-03-31SEC
2026-03-068-KCurrent report2026-03-06SEC
2026-01-124Statement of changes in beneficial ownership of securities2026-01-09SEC
2026-01-124Statement of changes in beneficial ownership of securities2026-01-09SEC
2026-01-124Statement of changes in beneficial ownership of securities2026-01-09SEC
2026-01-058-KCurrent report2026-01-05SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC2.58%
GEODE CAPITAL MANAGEMENT, LLC0.51%
CITADEL ADVISORS LLC0.47%
VANGUARD FIDUCIARY TRUST CO0.32%
STATE STREET CORP0.22%
Spinnaker Investment Group, LLC0.10%
NORTHERN TRUST CORP0.09%
Virtu Financial LLC0.09%
CHOREO, LLC0.07%
XTX Topco Ltd0.07%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.03%
VANGUARD EXTENDED MARKET INDEX FUND0.39%
Fidelity Extended Market Index Fund0.30%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.16%
Fidelity Series Total Market Index Fund0.08%
Fidelity Total Market Index Fund0.05%
Fidelity Nasdaq Composite Index Fund0.04%

OakChart. TOMZ. Cached 15 minutes.

Some panels did not load: ratings, insider.